Atos SE
OTC:AEXAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atos SE
OTC:AEXAD
|
FR |
|
N
|
Neurones SA
XBER:NE9
|
FR |
|
Sprinklr Inc
F:9EI
|
US |
|
SPX Corp
NYSE:SPXC
|
US |
|
I
|
Indivior PLC
F:2IV
|
UK |
|
S
|
SPX Corp
XBER:SPW
|
US |
|
L
|
Lakeland Industries Inc
F:LLI
|
US |
|
XL Axiata Tbk PT
F:E5F
|
ID |
|
E
|
Erste Group Bank AG
XHAM:EBO
|
AT |
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
S
|
Sturm Ruger & Company Inc
F:ST2
|
US |
|
Nuvei Corp
F:62E
|
CA |
|
T
|
Trinity Capital Inc
F:9F7
|
US |
Wall St Price Targets
AEXAD Price Targets Summary
Atos SE
According to Wall Street analysts, the average 1-year price target for AEXAD is 42.56 USD with a low forecast of 32.08 USD and a high forecast of 58.86 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AEXAD's stock price target?
Price Target
42.56
USD
According to Wall Street analysts, the average 1-year price target for AEXAD is 42.56 USD with a low forecast of 32.08 USD and a high forecast of 58.86 USD.
What is the Revenue forecast for Atos SE?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is -4%.
What is the Operating Income forecast for Atos SE?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 3 years is 21%.
